RECRUITING

High Potency Cannabis: Acute and Protracted Effects

Talk to us

Conditions

Abuse CannabisPainPharmacokineticsTHCCannabis

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this research is to assess the effects of smoked cananbis when cannabis is smoked during periods of cannabis use as usual and after a brief period of abstinence.

Official Title

High Potency Cannabis: Acute and Protracted Effects

Quick Facts

Study Start:2025-07-01
Study Completion:2028-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06859723

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 55 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * • Male or non-pregnant and non-lactating females aged 21-55 years
  2. * Report cannabis smoking near daily
  3. * Not currently seeking treatment for their cannabis use
  4. * Have a Body Mass Index from 18.5 - 34kg/m2.
  5. * Able to perform all study procedures
  6. * Must be using a contraceptive (hormonal or barrier methods)
  1. * Meeting DSM-V criteria for any substance use disorder other than cannabis, nicotine, caffeine
  2. * Do not have positive urine toxicology for cannabis use during screening
  3. * Evidence of severe psychiatric illness (e.g. mood or anxiety disorder with functional impairment or suicide risk, schizophrenia) judged by the study physician (and PI) to put the participant at greater risk of experiencing adverse events due to completion of study procedures, interfere with their ability to participate in the study, or their capacity to provide informed consent.
  4. * Report using other illicit drugs in the prior 4 weeks
  5. * Current predominant licit use of medical cannabis, prescription analgesics, or any medications that may affect study outcomes
  6. * Current pain
  7. * Pregnancy
  8. * Currently enrolled in another research protocol
  9. * Not using a contraceptive method (hormonal or barrier methods)
  10. * Insensitivity to the cold water stimulus of the Cold Pressor Test
  11. * Any disorders that might make cannabis administration hazardous as determined by evaluation physician after review of all medical assessments along with medical history.
  12. * Not able to speak and read English

Contacts and Locations

Study Contact

Ziva Cooper, PhD
CONTACT
310-206-9942
cannabislab@mednet.ucla.edu
Vincent Acebo
CONTACT
310-983-3417
vacebo@mednet.ucla.edu

Study Locations (Sites)

UCLA Center for Cannabis and Cannabinoids
Los Angeles, California, 90095
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-07-01
Study Completion Date2028-07-01

Study Record Updates

Study Start Date2025-07-01
Study Completion Date2028-07-01

Terms related to this study

Keywords Provided by Researchers

  • THC
  • Cannabis

Additional Relevant MeSH Terms

  • Abuse Cannabis
  • Pain
  • Pharmacokinetics